For more information or to access our media kit contact:
Joen T. Johansen
Corporate Communications
+1-781-376-0009
joen.johansen@advandx.com
Joen T. Johansen
Corporate Communications
+1-781-376-0009
joen.johansen@advandx.com
News & Events
Information for Journalists
In this section, members of the media can find helpful background information on AdvanDx and the PNA FISH and EVIGENE tests.
News
7.14.2008 | For more information, call the CAP Customer Contact Center at 1-800-323-4040, option 1.
Download Document [106.6 KB]
5.29.2008 | Ultimately, within the next several decades, every physician will be able to catch every infection as soon as it is detected, with a specific, tailored therapy for every patient.
Download Document [1.1 MB]
3.19.2008 | Woburn, MA, U.S.A - AdvanDx announced it received Frost & Sullivan's 2008 Technology Innovation of the Year Award in the field of rapid in-vitro molecular diagnostic technology. The award recognizes how hospitals depend on AdvanDx's easy-to-use, molecular-based PNA FISH™ diagnostics to quickly identify bloodstream pathogens in hours instead of days. The rapid PNA FISH results enable laboratories to report critical information to physicians and pharmacists earlier to ensure optimal therapy and help reduce mortality rates for patients afflicted with bloodstream infections.(1,2)
More Details »
More Details »
1.1.2008 | On January 1, 2008 bioMerieux, Inc. became the distributor of PNA FISH products in the United States. bioMerieux will process all orders and invoices, while AdvanDx will continue to develop, manufacture and ship products for our customers.
More Details »
More Details »
10.17.2007 | New Dual-Color PNA FISH tests are now available for rapid bacterial and fungal species identification to help improve care for patients with serious, bloodstream infections.
Follow Link »
Follow Link »
9.19.2007 | by Staff Reporters - AdvanDx Inc., a maker of hospital-targeted in vitro molecular diagnostic products, has raised a $15 million Series C funding round to increase the company's market penetration both nationally and internationally.
Follow Link »
Follow Link »
9.19.2007 | by Clifford Carlsen - AdvanDx Inc. raised $15 million in a Series C round from new distribution partner bioMérieux SA of France and longtime backers LD Pensions of Denmark and Sweden's Scandinavia Life Science Venture to support expansion of sales and marketing of tests for bloodstream infections and for development of a pipeline of new products.
Follow Link »
Page:
1 |
2
|
3
|
4
Follow Link »
Events
6.1.2008 | Please visit Booth #323 to learn more about AdvanDx and our products. Also, if you would to schedule an onsite meeting, send an e-mail to:
More Details »
More Details »
4.19.2008 | Please visit Booth #501 to learn more about AdvanDx and our products. Also, if you would to schedule an onsite meeting, send an e-mail to:
More Details »
More Details »
9.17.2007 | Sepsis: Learn more about how you can impact care for patients with septicemia by visiting Booth 753. Also, please join us for dinner.
More Details »
More Details »
5.1.2007 | Learn more about new PNA FISH products and how you can impact patient care by visiting Booth 223. Also, Join us for dinner.
More Details »
More Details »
3.30.2007 | March 31 - April 3, 2007, The Internationales Congress Center Munchen(ICM); Munich, Germany
More Details »
More Details »
2.22.2007 | February 17-21, 2007
Gaylord Palms Resort and Convention Center
Orlando, Florida, USA
Follow Link »
Follow Link »